Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Consensus Guidelines in the Management of Branch Duct Intraductal Papillary Mucinous Neoplasm: A Cost-Effectiveness Analysis
Digestive Diseases and Sciences, 10/21/09
Huang ES et al. – Immediate surgery is the most effective, but may be prohibitively expensive. The surveillance strategy is a cost–effective option compared to no surveillance.
Exclusive Author Commentary
Edward S. Huang, 10/21/09
Edward S. Huang, 10/21/09
| Branch duct intraductal papillary mucinous neoplasm (BD-IPMN) is an increasing entity that physicians find on CT scan. The big question is what to do with these lesions. Even though these lesions are pre-malignant, the literature suggests the rate of progression to malignancy is rather slow. This study addresses whether monitoring these lesions according to the consensus guidelines recommended by the International Association of Pancreatology is a reasonable strategy in comparison to surgery or doing nothing. |
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of Fistulizing Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/13/09
Safety Profile of IBD: Lymphoma Risks
Gastroenterology Clinics of North America, 11/16/09
Image-enhanced endoscopy in practice
Canadian Journal of Gastroenterology, 11/06/09
Sponsor
Article Search
Sponsor